Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
Me restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while ...
Essex Live on MSN10h
Girl trying to complete ‘visual wish list’ before she goes blind
A young girl diagnosed with a rare genetic condition which means she will lose her eyesight has begun a 'visual wish list' ...
People Are Sharing The Unusual Things Their Bodies Do That They Had No Idea Weren't Actually "Normal"
If you've been personally victimized by that weird, rain-stick like noise in the back of your neck, you might want to read ...
Bayer AG (BAYZF) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...
SurvivorNet on MSN13h
New CML Approval: Leading Leukemia Expert on the ‘Significant Improvement’ Asciminib (Scemblix) Offers Patients as a First-Line Treatment Option
For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...
Hosted on MSN15h
Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript November 4, 2024 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank ...
23andMe is laying off 40 percent of its staff
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
Orange County Register4h
Genetic testing giant 23andMe cuts 40% of workforce, discontinues therapeutics division
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
23andMe cuts 40% of its workforce and discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...